Good risk /reward is right! Wish I could buy more, but spent all my money on Viagra. Not for me - for my wife. I mean I bought the stock. But it didn't go up like I hoped. Maybe that's because all I bought was the stock. Anyway, good point that the FIBR price drop hasn't been on heavy trading. I suspect the price would get a boost if the earnings weren't due out so soon. It's probably worth waiting for results. Also waiting for details of EN (Net + Arm) spin off.
As an investor in PMTI when Nexar was spun off (with nothing for PMTI holders), I'm much happier with FIBR's treatment of stockholders in this situation. I'll probably buy the Net+Arm stock, depending on final details.
Does anyone know if this was a recommendation from Volpe? I would suspect that the $8 million deal and this spin off were suggested by them. If so, it really means a new era for FIBR. Instead of turning to former advisers with shady backgrounds, Par has listened to a respected advisor and acted accordingly. If someone can confirm that these growth oriented suggestions are from Volpe, I will find some way to invest more. Maybe even take my wife's Viagra away!
Even if earnings are not positive, this stock will rise faster than Pfiser if they announce contracts have been signed for GigaMux, Net+Arm, and/or IQX. I'll bet with the FORE exposure, they'll have some nice announcements. Good earnings at this point would just be icing on the cake.
|
